132 related articles for article (PubMed ID: 31768922)
1. Constitutive expression of c-REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome.
Singh MK; Singh L; Pushker N; Chosdol K; Bakhshi S; Meel R; Sen S; Kashyap S
Clin Transl Oncol; 2020 Jul; 22(7):1193-1204. PubMed ID: 31768922
[TBL] [Abstract][Full Text] [Related]
2. Identification of canonical NFκB (C-NFκB) pathway in uveal melanoma and their relation with patient outcome.
Singh MK; Singh L; Pushker N; Saini N; Meel R; Chosdol K; Bakhshi S; Sen S; Venkatesh P; Chawla B; Kaur J; Kashyap S
Clin Exp Metastasis; 2019 Jun; 36(3):271-290. PubMed ID: 31069565
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological relevance of NFκB1/p50 nuclear immunoreactivity and its relationship with the inflammatory environment of uveal melanoma.
Singh MK; Singh L; Chosdol K; Pushker N; Meel R; Bakhshi S; Sen S; Kashyap S
Exp Mol Pathol; 2019 Dec; 111():104313. PubMed ID: 31533021
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.
Singh MK; Singh L; Chosdol K; Pushker N; Saini N; Meel R; Bakhshi S; Sen S; Kashyap S
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2969-2982. PubMed ID: 31612319
[TBL] [Abstract][Full Text] [Related]
5. Does NEMO/IKKγ protein have a role in determining prognostic significance in uveal melanoma?
Singh MK; Pushker N; Meel R; Chodsol K; Sen S; Bakhshi S; Singh L; Kashyap S
Clin Transl Oncol; 2018 Dec; 20(12):1592-1603. PubMed ID: 29796997
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of BCL2 19 kD Protein-Interacting Protein 3 (BNIP3) is Predictive of Unfavorable Prognosis in Uveal Melanoma.
Jiang Z; Yu F; Li M
Med Sci Monit; 2018 Jul; 24():4711-4717. PubMed ID: 29982263
[TBL] [Abstract][Full Text] [Related]
7. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.
Jiang Z; Liu F
Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142
[TBL] [Abstract][Full Text] [Related]
8. Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma.
Topcu-Yilmaz P; Kiratli H; Saglam A; Söylemezoglu F; Hascelik G
Melanoma Res; 2010 Apr; 20(2):126-32. PubMed ID: 20061986
[TBL] [Abstract][Full Text] [Related]
9. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
10. DNA damage response proteins and its role in tumor progression of uveal melanoma with patient outcome.
Kashyap S; Jha J; Singh MK; Singh L; Sen S; Kaur J; Bajaj MS; Pushker N
Clin Transl Oncol; 2020 Sep; 22(9):1472-1480. PubMed ID: 32124242
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
[TBL] [Abstract][Full Text] [Related]
12. HIC1 modulates uveal melanoma progression by activating lncRNA-numb.
Cheng G; He J; Zhang L; Ge S; Zhang H; Fan X
Tumour Biol; 2016 Sep; 37(9):12779-12789. PubMed ID: 27449031
[TBL] [Abstract][Full Text] [Related]
13. PD-1 expression on uveal melanoma induces tumor proliferation and predicts poor patient survival.
Jiang Z; Yan Y; Dong J; Duan L
Int J Biol Markers; 2020 Sep; 35(3):50-58. PubMed ID: 32686562
[TBL] [Abstract][Full Text] [Related]
14. Expression of the metastasis suppressor gene KISS1 in uveal melanoma.
Martins CM; Fernandes BF; Antecka E; Di Cesare S; Mansure JJ; Marshall JC; Burnier MN
Eye (Lond); 2008 May; 22(5):707-11. PubMed ID: 18219339
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
Paraoan L; Gray D; Hiscott P; Ebrahimi B; Damato B; Grierson I
Exp Eye Res; 2006 Oct; 83(4):911-9. PubMed ID: 16784742
[TBL] [Abstract][Full Text] [Related]
16. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
[TBL] [Abstract][Full Text] [Related]
17. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of pepsinogen C in uveal melanomas.
Alvarez ML; González LO; Barbón JJ; Astudillo A; Vizoso FJ
Int J Biol Markers; 2004; 19(3):240-4. PubMed ID: 15503827
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical analysis of nm23 gene product expression in uveal melanoma.
Greco IM; Calvisi G; Ventura L; Cerrito F
Melanoma Res; 1997 Jun; 7(3):231-6. PubMed ID: 9195562
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
